Rybelsus 7 mg – Product Overview
💊 What is Rybelsus 7 mg?
Rybelsus 7 mg is a once-daily oral tablet used to manage blood sugar in adults with type 2 diabetes. It contains semaglutide, a GLP-1 receptor agonist that:
- Increases insulin secretion
- Reduces liver glucose production
- Slows stomach emptying
This helps improve overall glycemic control when diet and exercise alone aren’t enough.
🧪 How It Works
- Initial Dose: 3 mg is the starting dose to help your body adjust.
- After 30 days, most patients transition to a maintenance dose of 7 mg.
- If further control is needed, the dose can be increased to 14 mg.
🕒 How to Take It
- Take once daily on an empty stomach with up to 120 mL of water (about half a glass).
- Wait at least 30 minutes before eating, drinking, or taking other oral medications.
- Swallow whole—do not split, crush, or chew the tablet.
⚠️ Warnings & Precautions
- Not for type 1 diabetes or diabetic ketoacidosis.
- Risk of thyroid C-cell tumors—do not use if you or your family have a history of:
- Medullary thyroid carcinoma (MTC)
- Multiple endocrine neoplasia syndrome type 2 (MEN 2)
- Use caution if you have a history of pancreatitis or are on other diabetes medications.
📝 Quick Facts
Feature | Details |
---|---|
Generic Name | Semaglutide |
Brand Name | Rybelsus |
Strength | 3 mg (starter dose) |
Form | Oral tablet |
Used For | Type 2 diabetes |
Common Side Effects | Nausea, diarrhea, constipation |
Serious Risks | Thyroid tumors, pancreatitis |
👉 Always follow your doctor’s instructions and discuss any concerns or side effects before continuing treatment.